Resources Archive

Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.

The U.K. is one of the first governments to set out provisional plans for booster shots. It isconcerned that possible further Covid-19 outbreaks over the winter could coincide with awave of influenza and put pressure on the country’s health system

The developments underscore how the morphing pathogen continues to challenge a return to pre-pandemic life world-wide.

Trial results for a new Regeneron treatment have buoyed hopes that doctors could soon have a new way to tackle severe hospital cases.

The Delta strain is now a variant of concern, with indications it is more infectious than other strains.

The CDC is investigating a few dozen cases of myocarditis, an inflammation of the heart muscle, found in young adults and adolescent vaccine recipients.

Jabs could be tweaked to stop reaction happening, new research suggests

The spate of cases is a bad bounce—and it might show that lifting mask mandates for the vaxxed won’t be a grand slam.

In Mexico, about 80 people received fraudulent doses, and in Poland authorities recovered vials containing antiwrinkle drugs.

Breakthrough cases represent 0.008% of the fully vaccinated population and are in line with expectations because the approved vaccines in the U.S. are not 100% effective.

Due to variants of the coronavirus, people likely will need a booster shot within a year to suppress the pool of those individuals susceptible to Covid-19 per Pfizer Chief Executive Albert Bourla.

n participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well tolerated

The Wall Street Journal’s coverage of the pandemic, from the latest news to deeper looks into how the disease is affecting life and business.

A single shot of the Pfizer-BioNTech vaccine is 85% effective in preventing symptomatic disease 15 to 28 days after being administered, an Israeli study found.

A single shot of the Pfizer-BioNTech vaccine is 85% effective in preventing symptomatic disease 15 to 28 days after being administered, an Israeli study found.

“In the near future, travel may require digital documentation showing that passengers have been vaccinated
or tested for the coronavirus.”

Comparing the dangerous effects of three diseases with the minimal side effects of their corresponding vaccines.

“Times are tough now, but the end is in sight. If we hunker down, keep our families safe during the holidays and monitor our health at home, life will get better in the spring. Here’s how to get through it.”

Laboratory technologists have been working nonstop to help the nation diagnose an ever-growing number of coronavirus cases.

Wastewater testing is demonstrating the ability to predict an increase in COVID cases several days in advance.

A review of certain airline testing procedures and requirements.

A visual explanation of the immune response for a Covid-19 infection.

With fears of a “twindemic” in the United States this fall, here’s a guide to understanding what’s making you feel terrible.

Wastewater testing and tracking apps are being used to track potential student exposure.

PCR cycle thresholds may be critical to determine how infectious a person is.

Two European patients are confirmed to have been re-infected with COVID-19, raising concerns about people’s immunity to the coronavirus as the world struggles to tame the pandemic.

A review of the WHO response/limitations to the newly emerging SARS-CoV-2.

A research team at the University of Florida succeeded in isolating live virus from aerosols collected at a distance of seven to 16 feet from patients hospitalized with Covid-19 — farther than the six feet recommended in social distancing guidelines.